Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLNCF) Tax Provisions (2024 - 2025)

Historic Tax Provisions for Silence Therapeutics (SLNCF) over the last 2 years, with Q3 2025 value amounting to $1000.0.

  • Silence Therapeutics' Tax Provisions fell 9795.92% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $335000.0, marking a year-over-year change of. This contributed to the annual value of $845000.0 for FY2024, which is 1161.09% down from last year.
  • Latest data reveals that Silence Therapeutics reported Tax Provisions of $1000.0 as of Q3 2025, which was down 9795.92% from $10000.0 recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Tax Provisions registered a high of $324000.0 during Q4 2024, and its lowest value of $1000.0 during Q3 2025.